Status:
COMPLETED
Reducing Emergency Diabetes Care for Older African Americans
Lead Sponsor:
Thomas Jefferson University
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
40+ years
Phase:
PHASE3
Brief Summary
This RCT will compare the efficacy of Preventing and Reducing Emergency Visits in Diabetes through Education and Trust (PREVENT) vs. intensive home-based diabetes (DM) education \[i.e., Enhanced Usual...
Detailed Description
This Phase-III RCT will compare the efficacy of Preventing and Reducing Emergency Visits in Diabetes through Education and Trust (PREVENT) vs. intensive home-based DM education to reduce the number of...
Eligibility Criteria
Inclusion
- African American race (self-identified)
- Age ≥ 40 years
- Type 1 or 2 DM
- A DM-related cause for the ED visit in the opinion of the ED physician
- Has a Jefferson PCP (participants receiving PREVENT will have a telehealth visit with their Jefferson PCP).
Exclusion
- Medical or psychiatric morbidity (e.g., acute stroke, schizophrenia) that would preclude study participation in the opinion of the ED physician
- Clinically significant cognitive impairment
- Pregnancy
Key Trial Info
Start Date :
January 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2023
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT03466866
Start Date
January 10 2019
End Date
September 30 2023
Last Update
May 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107